Back
SpringWorks Therapeutics Stock Price Chart

Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
SWTX
SpringWorks Therapeutics
Last Price:
$36.47
Seasonality Move:
5.59%
7 Day Trial
ALL ACCESS PASS
$
7

This is going to be BIG...
You can get in on the action now by following this link.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SpringWorks Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.68 | Sell |
20-day SMA: | 44.15 | Sell |
50-day SMA: | 47.64 | Sell |
200-day SMA: | 39.12 | Sell |
8-day EMA: | 38.33 | Sell |
20-day EMA: | 42.57 | Sell |
50-day EMA: | 44.67 | Sell |
200-day EMA: | 40.98 | Sell |
SpringWorks Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.57 | Sell |
Relative Strength Index (14 RSI): | 35.73 | Sell |
Chaikin Money Flow: | 1959844 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.9 - 50.92) | Sell |
Bollinger Bands (100): | (35.39 - 50.17) | Sell |
SpringWorks Therapeutics Technical Analysis
Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 36.47 while SWTX 8-day simple moving average is 38.68, which is a Sell signal.
-
The stock price of SWTX is 36.47 while SpringWorks Therapeutics 20-day SMA is 44.15, which makes it a Sell.
-
SpringWorks Therapeutics 50-day simple moving average is 47.64 while SWTX share price is 36.47, making it a Sell technically.
-
SWTX stock price is 36.47 and SpringWorks Therapeutics 200-day simple moving average is 39.12, creating a Sell signal.
SWTX Technical Analysis vs Fundamental Analysis
Sell
20
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a SellThe current SpringWorks Therapeutics [SWTX] share price is $36.47. The Score for SWTX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
2.7B
Price in USD:
36.47
Share Volume:
2M
SpringWorks Therapeutics 52-Week Range
52-Week High:
62.00
52-Week Low:
28.21
Sell
20
SpringWorks Therapeutics (SWTX)
is a Sell
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?The SpringWorks Therapeutics stock price is 36.47 USD today.
-
Will SWTX stock go up or go down?SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is SpringWorks Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is overvalued.
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 36.47 while SWTX 8-day exponential moving average is 38.33, which is a Sell signal.
-
The stock price of SWTX is 36.47 while SpringWorks Therapeutics 20-day EMA is 42.57, which makes it a Sell.
-
SpringWorks Therapeutics 50-day exponential moving average is 44.67 while SWTX share price is 36.47, making it a Sell technically.
-
SWTX stock price is 36.47 and SpringWorks Therapeutics 200-day simple moving average is 40.98, creating a Sell signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $2.00 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
-
SWTX Moving Average Covergence Divergence (MACD) indicator is -3.57, suggesting SpringWorks Therapeutics is a Sell
-
SpringWorks Therapeutics Relative Strength Index (RSI) is 35.73, which suggest SpringWorks Therapeutics is oversold
-
The Bollinger Bands (25) for SpringWorks Therapeutics is (39.9 - 50.92), which suggest SpringWorks Therapeutics is a Sell
-
The Bollinger Bands (100) for SpringWorks Therapeutics is (35.39 - 50.17), which suggest SpringWorks Therapeutics is a Sell
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.